Trevi Therapeutics

@TreviThera

Trevi is a clinical-stage biopharma company currently developing the investigational oral therapy Haduvio™ (nalbuphine ER) for serious chronic cough conditions.

Connecticut trevitherapeutics.com Joined August 2011

117 Following 302 Followers 605 Posts

Latest posts 5

Trevi Therapeutics @TreviThera 1d

Join Trevi senior leadership for a fireside chat at the @Stifel Healthcare Conference on Nov 11 at 10:00 a.m. ET.

Read the press release for details: ow.ly/Jeme51052eT

#ControllingCoughWhereItCounts

Trevi Therapeutics @TreviThera 2d

Reminder to tune in today, November 9th, at 4:30 p.m. ET for Trevi’s 3Q 2026 Earnings Call.

Webcast Registration: edge.media-server.com/mmc/p/448r63x4/

PR: ir.trevitherapeutics.com/news-releases/…

$TRVI #Earnings3Q #ChronicCough

Trevi Therapeutics @TreviThera Nov 2

Mark your calendars for Trevi’s 3Q 2026 Earnings Call on November 9th at 4:30 p.m. ET.

Register here to listen to the live webcast: ow.ly/hvq051038Qj

For more details: ow.ly/gZ7a51038PB

$TRVI #Earnings3Q #ChronicCough

Trevi Therapeutics @TreviThera Oct 29

On Oct 28 in Washington, D.C., patients living with chronic cough spoke to regulators, researchers, and industry at Let's Talk Cough, the first EL-PFDD meeting for chronic cough.

Thank you to every patient who shared their story and to the advocacy community.

#LetsTalkCough

Trevi Therapeutics @TreviThera Oct 27

This November, Trevi Therapeutics will be at the @Stifel 2026 Healthcare Conference.

Jennifer Good, President and CEO, and David Hastings, CFO, will join a fireside chat on November 11th at 10:00 a.m. ET.

PR: ow.ly/vj2j5101h2y

#ControllingCoughWhereItCounts